Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | CEO, AIS | September 03, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date September 03, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 41,533 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 798 · Balance 41,533 F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 4, 2026 20:46 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 798 | $70.56 | $56,306.88 |
DisclosureSEC source: 0002027284-26-000013 · wk-form4_1788554780.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,533 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 340 | $71.23 | $24,218.20 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 3 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,331 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 226 | $71.23 | $16,097.98 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:18 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 290 | $71.23 | $20,656.70 |
DisclosureSEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,897 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 16,458 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000008 · wk-form4_1779221108.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AIS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,187 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 24,598 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · derivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,598 Underlying: Common Stock, par value $0.01 per share · 24,598 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 9,356 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,729 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,174 | $79.20 | $92,980.80 |
DisclosureSEC source: 0002027284-26-000004 · wk-form4_1771373829.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,373 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,154 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000004 · wk-form4_1771373829.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,547 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 189 | $78.97 | $14,925.33 |
DisclosureSEC source: 0002027284-26-000002 · wk-form4_1770163334.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,393 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,388 | $73.73 | $102,337.24 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 4 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,582 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 204 | $73.73 | $15,040.92 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 3 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,970 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 134 | $73.73 | $9,879.82 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,174 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 165 | $73.73 | $12,165.45 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,308 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:41 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 14,058 | $0.00 Strike: $86.45 | $0.00 |
DisclosureSEC source: 0001628280-25-010702 · wk-form4_1741221653.xml · derivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,058 Underlying: Common Stock, par value $0.01 per share · 14,058 shares Expires 2035-03-03 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:41 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010702 · wk-form4_1741221653.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,473 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:20 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 158 | $88.30 | $13,951.40 |
DisclosureSEC source: 0001628280-25-003729 · wk-form4_1738704009.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,557 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 05, 2024 Filed Nov 5, 2024 21:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 900 | $87.63 | $78,867.00 |
DisclosureSEC source: 0001628280-24-045277 · wk-form4_1730840792.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,715 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $87.63 to $87.66, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:07 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 165 | $84.82 | $13,995.30 |
DisclosureSEC source: 0001628280-24-039307 · wk-form4_1725480433.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, Ultrasound & IGT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,615 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:07 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,388 | $84.82 | $117,730.16 |
DisclosureSEC source: 0001628280-24-039307 · wk-form4_1725480433.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, Ultrasound & IGT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,780 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 6,203 | $0.00 Strike: $85.30 | $0.00 |
DisclosureSEC source: 0001628280-24-037701 · wk-form4_1724098544.xml · derivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, Ultrasound & IGT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,203 Underlying: Common Stock, par value $0.01 per share · 6,203 shares Expires 2034-08-15 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:15 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037701 · wk-form4_1724098544.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, Ultrasound & IGT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,168 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.